ARTICLES
First-Line Ofatumumab Approved by FDA for Chemotherapy-Ineligble Patients With CLL
The FDA has approved ofatumumab (Azerra) plus chlorambucil for previously untreated patients with chronic lymphocytic leukemia (CLL) who are considered inappropriate for treatment with fludarabine therapy.
More than 50% of melanoma involves mutation in the BRAF protein, which is part of the mitogen-activated protein kinase (MAPK) signal transduction pathway.
2014 Volume 2 Number 1
Anna Azvolinsky, PhD
The first combination therapy for advanced melanoma received approval from the Food and Drug Administration (FDA) January 2014.
2014 Volume 2 Number 1
Anna Azvolinsky, PhD
Melanoma experts and researchers have gained ground in the development of novel and effective immunotherapies as well as targeted agents for those patients with metastatic melanoma who harbor specific tumor mutations.
2014 Volume 2 Number 1
Keith T. Flaherty, MD, discusses the latest and forthcoming research regarding MEK/BRAF combination therapies.
2014 Volume 2 Number 1
Dosing Frequency and Adherence in Patients With Nonvalvular Atrial Fibrillation
Tanya Burton, PhD; Ying Fan, MS; and Winghan Jacqueline Kwong, PharmD, PhD
Medications with once-daily dosing are associated with better adherence than those with twice-daily dosing. Simplifying dosing frequency provides opportunity to improve medication adherence in NVAF patients.
2014 Volume 6 Number 2
An Analysis of Intravenous Immunoglobin Site of Care: Home Versus Outpatient Hospital
Rakesh Luthra, MS; Ralph Quimbo, MA; Ravi Iyer, PhD; and Michelle Luo, PhD
This retrospective study compares treatment adherence and healthcare costs for primary immunodeficiency patients receiving intravenous immunoglobulin in home and outpatient settings.
2014 Volume 6 Number 2
The American Cancer Society estimates that more than 75,000 new cases of melanoma will be diagnosed in 2014, and that nearly 10,000 people will die of melanoma this year.
2014 Volume 2 Number 1
The Significance of Pharmacy Interventions: An Updated Review in the Presence of Electronic Order Entry
Megan E. Sartore, PharmD; Kimberly M. Ehman, PharmD; and Chester B. Good, MD, MPH
This study examines the results of therapeutic interventions performed by pharmacists at the Veterans Affairs Pittsburgh Healthcare System and their relevance to electronic medical records.
2014 Volume 6 Number 2